Dr. Vikas Singh is a highly respected Consultant Urologist and Transplant Surgeon in Indore, recognized for his expertise in performing advanced kidney transplant procedures including laparoscopic donor nephrectomy. Kidney transplantation represents the gold standard treatment for end-stage renal disease, offering patients with kidney failure a chance to return to normal life without dialysis. Dr. Singh’s comprehensive transplant program at Kokilaben Dhirubhai Ambani Hospital combines cutting-edge surgical techniques, including minimally invasive laparoscopic donor surgery, with exceptional post-transplant care to ensure optimal outcomes for both recipients and living donors. The laparoscopic approach for donor nephrectomy offers living kidney donors the benefits of smaller incisions, less pain, faster recovery, and better cosmetic results compared to traditional open surgery, while maintaining the same excellent kidney function for recipients. Dr. Singh’s expertise spans the entire transplant journey—from pre-transplant evaluation and donor workup through surgery and long-term follow-up care. We maintain complete transparency regarding treatment protocols, costs, and provide thorough guidance for patients and families navigating the kidney transplant process across Central India.
Consultant Transplant Surgeon at Kokilaben Dhirubhai Ambani Hospital, Indore, equipped with state-of-the-art transplant facilities and ICU care.
Full-service program covering donor evaluation, recipient preparation, surgery, immunosuppression management, and lifelong follow-up.
Expertise in minimally invasive donor nephrectomy offers living donors significantly improved recovery and quality of life.
Kidney transplantation is the most effective treatment for end-stage renal disease (ESKD), offering dramatically improved quality of life, longer survival, and freedom from dialysis compared to ongoing dialysis therapy. A successful transplant allows patients to return to normal activities, work, travel, and enjoy life without the restrictions and time burden of regular dialysis sessions. Transplant kidneys can come from living donors (family members, spouses, friends, or altruistic donors) or deceased donors. Living donor transplants generally offer better outcomes, shorter waiting times, and the ability to schedule surgery at optimal times for both donor and recipient.
During transplant surgery, a healthy kidney from a donor is placed in the recipient's lower abdomen (typically right side), connected to the recipient's blood vessels and bladder. The recipient's own failed kidneys are usually left in place unless there's a specific medical reason for removal. The transplanted kidney begins functioning immediately or within days, taking over the work of filtering blood and producing urine. Recipients require lifelong immunosuppressive medications to prevent rejection of the transplanted kidney. With proper care and medication compliance, transplanted kidneys can function for 15-20 years or longer from living donors, and 10-15 years from deceased donors.
Kidney transplant is indicated for patients with end-stage renal disease from various causes including diabetes, hypertension, glomerulonephritis, polycystic kidney disease, chronic kidney infections, or congenital kidney problems. Ideal candidates are patients on dialysis or approaching the need for dialysis (GFR under 20 ml/min), who are otherwise healthy enough to tolerate surgery and long-term immunosuppression. Age is not an absolute barrier—patients from children to those in their 70s can be successfully transplanted. Comprehensive medical evaluation ensures candidates can safely undergo transplant and maintain the graft long-term.
The transplant journey begins with comprehensive evaluation of both recipient and potential donor. Recipients undergo extensive testing including blood work, cardiac evaluation, infectious disease screening, cancer screening, and psychosocial assessment to ensure they’re suitable candidates. Potential living donors undergo equally thorough evaluation including kidney function tests, imaging, blood typing, cross-matching, and medical/psychological assessment to ensure donation is safe and appropriate. This evaluation phase typically takes 2-4 weeks and ensures both parties are fully prepared and informed.
For living donor transplants, Dr. Singh performs advanced laparoscopic donor nephrectomy, removing the donor kidney through small incisions (typically 3-4 tiny ports plus one 6-8cm extraction incision). Using high-definition cameras and specialized instruments, the donor kidney is carefully dissected, its blood vessels and ureter are divided, and the kidney is extracted through a small Pfannenstiel incision (similar to C-section incision). This minimally invasive approach offers donors significantly less pain, shorter hospital stay (2-3 days vs 5-7 days with open surgery), faster return to normal activities (2-3 weeks vs 6-8 weeks), and excellent cosmetic results. The donor’s remaining kidney compensates fully, providing normal kidney function for life.
The recipient surgery is typically performed as open surgery through a curved lower abdominal incision. The donor kidney is placed in the iliac fossa (lower abdomen), and its artery and vein are connected to the recipient’s iliac vessels. The ureter is connected to the bladder to allow urine drainage. The surgery takes 3-4 hours, and patients are monitored closely in ICU for 24-48 hours post-operatively. The transplanted kidney often begins producing urine immediately on the operating table, though some kidneys take a few days to start functioning. Recipients typically stay in hospital for 5-7 days for monitoring and medication adjustment.
This advanced approach uses small incisions and specialized instruments to remove the donor kidney. Benefits include significantly less post-operative pain, smaller scars (3-4 tiny ports plus one 6-8cm incision), shorter hospital stay (2-3 days), faster return to work (2-3 weeks), reduced blood loss, and better cosmetic outcomes. Recovery is dramatically improved compared to open surgery, making donation more acceptable to potential donors. Kidney quality and recipient outcomes are identical to open surgery. Primary Advantages: Minimal pain, rapid recovery, excellent cosmesis, shorter hospitalization, earlier return to normal life.
Traditional open surgery uses a large flank incision (20-25cm) between the ribs and hip. While this provides excellent exposure and has been the gold standard for decades, it involves significantly more post-operative pain, longer hospital stay (5-7 days), extended recovery (6-8 weeks), larger visible scar, and higher risk of incisional hernias. Open surgery may still be preferred in complex cases or when laparoscopic equipment is unavailable. Key Difference: Large incision with prolonged recovery vs. small incisions with rapid recovery; similar kidney outcomes for recipients.
Robotic-assisted laparoscopic surgery offers even greater precision and may further reduce donor morbidity in experienced hands. However, equipment availability and cost considerations make standard laparoscopic approach the most widely available minimally invasive option, offering excellent outcomes with proven safety. Key Difference: Enhanced precision but higher cost and limited availability vs. widely accessible laparoscopic technique with proven results.
No more spending 12-15 hours weekly at dialysis centers—transplant recipients regain freedom to work, travel, and live without dialysis schedules.
Transplant recipients live significantly longer and enjoy dramatically better quality of life compared to remaining on dialysis long-term.
Relief from the strict dietary restrictions and fluid limitations required on dialysis—eat and drink normally with few restrictions.
Laparoscopic donor surgery makes living donation more acceptable, with minimal scarring and rapid return to normal activities within weeks.
Schedule a private, confidential consultation with Dr. Singh in Indore.
Living donor kidney transplants typically function for 15-20 years or longer, while deceased donor kidneys average 10-15 years. However, many transplants last much longer—some patients maintain functioning grafts for 25-30+ years. Longevity depends on several factors including donor quality, recipient age and health, medication compliance (most important factor), management of blood pressure and diabetes, avoiding infections, and early detection and treatment of rejection episodes. The single most critical factor is taking immunosuppressive medications exactly as prescribed without missing doses. Younger recipients and living donor transplants generally have better long-term outcomes. With good care, many patients require only one transplant in their lifetime, while others may need a second transplant years or decades later.
Living kidney donation is generally very safe with modern techniques, particularly laparoscopic surgery. Short-term risks include standard surgical risks (bleeding, infection, pain) which are minimized with minimally invasive approach. Long-term studies show donors live just as long as matched non-donors and have no increased risk of kidney failure. The remaining kidney compensates fully, increasing its function by 30-40% to provide all the filtration capacity needed for normal health. Donors are carefully screened to ensure they have excellent kidney function, normal blood pressure, no diabetes, and no kidney disease before approval. Post-donation, donors are monitored long-term and maintain normal, healthy lives. The laparoscopic approach makes recovery much easier with most donors returning to full activities within 3-4 weeks.
All transplant recipients require lifelong immunosuppressive medications to prevent rejection. The typical regimen includes three medications: a calcineurin inhibitor (tacrolimus or cyclosporine), an antiproliferative agent (mycophenolate), and steroids (prednisone), though protocols vary. These medications must be taken exactly as prescribed at specific times daily. Common side effects include increased infection risk (most significant), elevated blood sugar, high blood pressure, tremor, stomach upset, and bone thinning. Some medications cause cosmetic effects like gum overgrowth or excess hair growth. Most side effects are manageable with medication adjustments or additional treatments. The benefits of a functioning transplant dramatically outweigh the medication side effects. Regular monitoring allows early detection and management of any complications.
Rejection occurs when your immune system recognizes the transplanted kidney as foreign and attacks it. There are two types: acute rejection (occurs in first year, affects 10-20% of patients) and chronic rejection (slow, progressive damage over years). Acute rejection is usually detected through routine blood work showing rising creatinine levels, though some patients develop symptoms like decreased urine output, fever, or graft tenderness. When detected early through monitoring, acute rejection is highly treatable with medication adjustments or high-dose steroids—most episodes are reversed without permanent damage. This is why frequent monitoring is crucial in the first year. Chronic rejection develops more slowly and is often related to medication non-compliance, recurring infections, or antibody development. The best prevention for rejection is taking medications exactly as prescribed and attending all follow-up appointments.
Recovery timelines vary by individual health and type of work. Most recipients can resume light activities and short walks immediately. Desk jobs typically can restart at 6-8 weeks, while physically demanding work may require 10-12 weeks or longer. You can generally resume driving once off narcotic pain medications (typically 2-3 weeks). Exercise can gradually resume starting at 6 weeks, building up to full activity by 3 months. Travel is possible once kidney function is stable and you’re on maintenance immunosuppression, typically after 3-6 months, though you should stay near medical care initially. Sexual activity can generally resume at 4-6 weeks. Most recreational activities are permissible with appropriate precautions—avoid contact sports that could injure the transplanted kidney. Within 3-6 months, most recipients return to fully normal, active lives with few restrictions beyond medication compliance and infection precautions.
Yes, transplant recipients can have normal family lives. Women with stable kidney function can have successful pregnancies, though this requires careful planning and management. You should wait at least 1-2 years post-transplant for kidney function to stabilize before conceiving, and pregnancy must be managed by high-risk obstetric specialists working closely with your transplant team. Some immunosuppressive medications need adjustment before and during pregnancy. Male recipients can father children without specific concerns beyond general health considerations. Children of transplant recipients are not at increased risk beyond any genetic factors that caused the original kidney disease. Many transplant recipients successfully raise families and live full, normal lives. The freedom from dialysis schedules makes family activities, parenting responsibilities, and work-life balance dramatically easier.
The leading center for advanced, compassionate urological care and treatment in Indore, Madhya Pradesh.
